Effects of phospholipase A2 and its products on structural stability of human LDL: Relevance to formation of LDL-derived lipid droplets

Journal of Lipid Research

Volumn 52, Issue 3, 2011, Pages 549-557

  Jayaraman, Shobini ^a   Gantz, Donald L ^a   Gursky, Olga ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Albumin; Atherosclerosis; Free fatty acids; Lipoprotein fusion and rupture; Lipoprotein oxidation; Thermal stability

Indexed keywords

ALBUMIN; APOLIPOPROTEIN B; FATTY ACID; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; PHOSPHOLIPASE A2; VERY LOW DENSITY LIPOPROTEIN;

ARTICLE; ATHEROSCLEROSIS; BETA SHEET; CIRCULAR DICHROISM; CONTROLLED STUDY; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LIPID HYDROLYSIS; LIPID OXIDATION; LIPOLYSIS; MOLECULAR STABILITY; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN MODIFICATION; PROTEIN STRUCTURE;

FATTY ACIDS, NONESTERIFIED; HUMANS; HYDROLYSIS; LIPOPROTEINS, LDL; PHOSPHOLIPASES A2; PROTEIN STABILITY;

EID: 79953171886     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M012567     Document Type: Article

References (51)

1. Williams, K. J., and I. Tabas. 1995. The response-to-retention hypothesis of early atherogenesis. Arterioscler. Thromb. Vasc. Biol. 15: 551-561.
2. Camejo, G., E. Hurt-Camejo, O. Wiklund, and G. Bondjers. 1998. Association of apo B lipoproteins with arterial proteoglycans: pathological significance and molecular basis. Atherosclerosis. 139: 205-222. (Pubitemid 28361804)
3. Skålén, K., M. Gustafsson, E. K. Rydberg, L. M. Hultén, O. Wiklund, T. L. Innerarity, and J. Borén. 2002. Subendothelial retention of atherogenic lipoproteins in early atherosclerosis. Nature. 417: 750-754. (Pubitemid 34640629)
4. Chisolm, G. M., and D. Steinberg. 2000. The oxidative modification hypothesis of atherogenesis:an overview. Free Radic. Biol. Med. 28:1815-1826.
5. de Winther, M. P., and M. H. Hofker. 2000. Scavenging new insights into atherogenesis. J. Clin. Invest. 105:1039-1041.
6. Oörni, K., M. O. Pentikäinen, M. Ala-Korpela, and P. T. Kovanen. 2000. Aggregation, fusion, and vesicle formation of modified low density lipoprotein particles:molecular mechanisms and effects on matrix interactions. J. Lipid Res. 41:1703-1714.
7. Guyton, J. R., and K. F. Klemp. 1994. Development of the atherosclerotic core region. Chemical and ultrastructural analysis of microdissected atherosclerotic lesions from human aorta. Arterioscler. Thromb. 14:1305-1314.
8. De Spirito, M., R. Brunelli, G. Mei, F. R. Bertani, G. Ciasca, G. Greco, M. Papi, G. Arcovito, F. Ursini, and T. Parasassi. 2006. Low density lipoprotein aged in plasma forms clusters resembling subendothelial droplets:aggregation via surface sites. Biophys. J. 90: 4239-4247. (Pubitemid 43846138)
9. Guyton, J. R. 2001. Phospholipid hydrolytic enzymes in a 'cesspool' of arterial intimal lipoproteins:a mechanism for atherogenic lipid accumulation. Arterioscler. Thromb. Vasc. Biol. 21:884-886.
10. Plihtari, R., E. Hurt-Camejo, K. Oörni, and P. T. Kovanen. 2010. Proteolysis sensitizes LDL particles to phospholipolysis by secretory phospholipase A2 group V and secretory sphingomyelinase. J. Lipid Res. 51:1801-1809.
11. Greco, G., G. Balogh, R. Brunelli, G. Costa, M. De Spirito, L. Lenzi, G. Mei, F. Ursini, and T. Parasassi. 2009. Generation in human plasma of misfolded, aggregation-prone electronegative low density lipoprotein. Biophys. J. 97:628-635.
12. Liu, H., D. G. Scraba, and R. O. Ryan. 1993. Prevention of phospholipase-C induced aggregation of low density lipoprotein by amphipathic apolipoproteins. FEBS Lett. 316:27-33.
13. Gursky, O. 2005. Apolipoprotein structure and dynamics. Curr. Opin. Lipidol. 16:287-294.
14. Jayaraman, S., D. L. Gantz, and O. Gursky. 2005. Structural basis for thermal stability of human low-density lipoprotein. Biochemistry. 44: 3965-3971. (Pubitemid 40358048)
15. Jayaraman, S., D. L. Gantz, and O. Gursky. 2007. Effects of oxidation on the structure and stability of human low-density lipoprotein. Biochemistry. 46:5790-5797. (Pubitemid 46764127)
16. Hakala, J. K., K. Oörni, M. O. Pentikäinen, E. Hurt-Camejo, and P. T. Kovanen. 2001. Lipolysis of LDL by human secretory phospholipase A(2) induces particle fusion and enhances the retention of LDL to human aortic proteoglycans. Arterioscler. Thromb. Vasc. Biol. 21:1053-1058.
17. Oörni, K., and P. T. Kovanen. 2009. Lipoprotein modification by secretory phospholipase A(2) enzymes contributes to the initiation and progression of atherosclerosis. Curr. Opin. Lipidol. 20: 421-427.
18. Davis, B., G. Koster, L. J. Douet, M. Scigelova, G. Woffendin, J. M. Ward, A. Smith, J. Humphries, K. G. Burnand, C. H. Macphee, et al. 2008. Electrospray ionization mass spectrometry identifies substrates and products of lipoprotein-associated phospholipase A2 in oxidized human low density lipoprotein. J. Biol. Chem. 283:6428-6437.
19. Yedgar, S., Y. Cohen, and D. Shoseyov. 2006. Control of phospholipase A2 activities for the treatment of inflammatory conditions. Biochim. Biophys. Acta. 1761:1373-1382.
20. Jönsson-Rylander, A. C., S. Lundin, B. Rosengren, C. Pettersson, and E. Hurt-Camejo. 2008. Role of secretory phospholipases in atherogenesis. Curr. Atheroscler. Rep. 10:252-259.
21. Corson, M. A. 2009. Emerging inflammatory markers for assessing coronary heart disease risk. Curr. Cardiol. Rep. 11:452-459.
22. Rosenson, R. S., and M. H. Gelb. 2009. Secretory phospholipase A2:a multifaceted family of proatherogenic enzymes. Curr. Cardiol. Rep. 11:445-451.
23. Macphee, C. H., J. J. Nelson, and A. Zalewski. 2005. Lipoprotein- associated phospholipase A2 as a target of therapy. Curr. Opin. Lipidol. 16:442-446.
24. Wilensky, R. L., Y. Shi, E. R. Mohler, D. Hamamdzic, M. E. Burgert, J. Li, A. Postle, R. S. Fenning, J. G. Bollinger, B. E. Hoffman, et al. 2008. Inhibition of lipoprotein-associated phospholipase A2 reduces complex coronary atherosclerotic plaque development. Nat. Med. 14:1059-1066.
25. Wilensky, R. L., and C. H. Macphee. 2009. Lipoprotein-associated phospholipase A(2) and atherosclerosis. Curr. Opin. Lipidol. 20: 415-420.
26. Braun, L. T., and M. H. Davidson. 2010. Lp-PLA2: a new target for statin therapy. Curr. Atheroscler. Rep. 12:29-33.
27. White, H. 2010. Editorial: why inhibition of lipoprotein-associated phospholipase A2 has the potential to improve patient outcomes. Curr. Opin. Cardiol. 25:299-301.
28. Gaubatz, J. W., B. K. Gillard, J. B. Massey, R. C. Hoogeveen, M. Huang, E. E. Lloyd, J. L. Raya, C. Y. Yang, and H. J. Pownall. 2007. Dynamics of dense electronegative low density lipoproteins and their preferential association with lipoprotein phospholipase A(2). J. Lipid Res. 48:348-357.
29. Bancells, C., S. Villegas, F. J. Blanco, S. Benitez, I. Gallego, L. Beloki, M. Perez-Cuellar, J. Ordonez-Llanos, and J. L. Sanchez-Quesada. 2010. Aggregated electronegative low-density lipoprotein in human plasma shows high tendency to phospholipolysis and particle fusion. J. Biol. Chem. 285:32425-32435.
30. Brown, W. J., K. Chambers, and A. Doody. 2003. Phospholipase A2 (PLA2) enzymes in membrane trafficking:mediators of membrane shape and function. Traffic. 4:214-221. (Pubitemid 36665382)
31. Chernomordik, L. V., and M. M. Kozlov. 2008. Mechanics of membrane fusion. Nat. Struct. Mol. Biol. 15:675-683.
32. Desbois, A. P., and V. J. Smith. 2010. Antibacterial free fatty acids: activities, mechanisms of action and biotechnological potential. Appl. Microbiol. Biotechnol. 85:1629-1642.
33. Chung, B. H., G. A. Tallis, B. H. Cho, J. P. Segrest, and Y. Henkin. 1995. Lipolysis-induced partitioning of free fatty acids to lipoproteins: effect on the biological properties of free fatty acids. J. Lipid Res. 36:1956-1970.
34. Lähdesmäki, K., R. Plihtari, P. Soininen, E. Hurt-Camejo, M. Ala-Korpela, K. Oörni, and P. T. Kovanen. 2009. Phospholipase A(2)-modified LDL particles retain the generated hydrolytic products and are more atherogenic at acidic pH. Atherosclerosis. 207: 352-359.
35. Schumaker, V. N., and D. L. Puppione. 1986. Sequential flotation ultracentrifugation. Methods Enzymol. 128:155-170.
36. Hakala, J. K., K. Oörni, M. Ala-Korpela, and P. T. Kovanen. 1999. Lipolytic modification of LDL by phospholipase A2 induces particle aggregation in the absence and fusion in the presence of heparin. Arterioscler. Thromb. Vasc. Biol. 19:1276-1283.
37. Smith, E. B. 1990. Transport, interactions and retention of plasma proteins in the intima:the barrier function of the internal elastic lamina. Eur. Heart J. 11 (Suppl. E):72-81.
38. Parthasarathy, S., and J. Barnett. 1990. Phospholipase A2 activity of low density lipoprotein:evidence for an intrinsic phospholipase A2 activity of apoprotein B-100. Proc. Natl. Acad. Sci. USA. 87: 9741-9745.
39. Reisfeld, N., D. Lichtenberg, A. Dagan, and S. Yedgar. 1993. Apolipoprotein B exhibits phospholipase A1 and phospholipase A2 activities. FEBS Lett. 315:267-270.
40. Esterbauer, H., J. Gebicki, H. Puhl, and G. Jürgens. 1992. The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Radic. Biol. Med. 13:341-390.
41. Skipski, V. P., M. Barclay, R. K. Barclay, V. A. Fetzer, J. J. Good, and F. M. Archibald. 1967. Lipid composition of human serum lipoproteins. Biochem. J. 104:340-352.
42. Folch, J., M. Lees, and G. H. Sloane Stanley. 1957. A simple method for the isolation and purification of total lipides from animal tissues. J. Biol. Chem. 226:497-509.
43. Morrison, W. R., and L. M. Smith. 1964. Preparation of fatty acid methyl esters and dimethylacetals from lipids with boron fluoride-methanol. J. Lipid Res. 5:600-608.
44. Myher, J. J., A. Kuksis, and S. Pind. 1989. Molecular species of glycerophospholipids and sphingomyelins of human erythrocytes: improved method of analysis. Lipids. 24:396-407. (Pubitemid 19144929)
45. Benjwal, S., S. Verma, K. H. Röhm, and O. Gursky. 2006. Monitoring protein aggregation during thermal unfolding in circular dichroism experiments. Protein Sci. 15:635-639.
46. Scanu, A., and R. Hirz. 1968. Human serum low-density lipoprotein protein:its conformation studied by circular dichroism. Nature. 218:200-201.
47. Prassl, R., M. Pregetter, H. Amenitsch, M. Kriechbaum, R. Schwarzenbacher, J. M. Chapman, and P. Laggner. 2008. Low density lipoproteins as circulating fast temperature sensors. PLoS One. 3(12):e4079.
48. Deckelbaum, R. J., R. Ramakrishnan, S. Eisenberg, T. Olivecrona, and G. Bengtsson-Olivecrona. 1992. Triacylglycerol and phospholipid hydrolysis in human plasma lipoproteins:role of lipoprotein and hepatic lipase. Biochemistry. 31:8544-8551.
49. Zhang, W. Y., E. Schwartz, Y. Wang, J. Attrep, Z. Li, and P. Reaven. 2006. Elevated concentrations of nonesterified fatty acids increase monocyte expression of CD11b and adhesion to endothelial cells. Arterioscler. Thromb. Vasc. Biol. 26:514-519.
50. Guha, M., and O. Gursky. 2010. Effects of oxidation on structural stability and remodeling of human very low density lipoprotein. Biochemistry. 49:9584-9593.
51. Wang, L., M. T. Walsh, and D. M. Small. 2006. Apolipoprotein B is conformationally flexible but anchored at a triolein/water interface: a possible model for lipoprotein surfaces. Proc. Natl. Acad. Sci. USA. 103:6871-6876.